Short Interest in BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Declines By 85.7%

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the recipient of a significant drop in short interest in the month of August. As of August 15th, there was short interest totaling 100 shares, adropof85.7% from the July 31st total of 700 shares. Based on an average daily volume of 52,400 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily volume of 52,400 shares, the days-to-cover ratio is presently 0.0 days.

BriaCell Therapeutics Stock Up 8.8%

BCTXW stock traded up $0.00 during midday trading on Tuesday, hitting $0.03. The stock had a trading volume of 2,136 shares, compared to its average volume of 75,246. The stock has a 50-day simple moving average of $0.04 and a 200 day simple moving average of $0.08. BriaCell Therapeutics has a 52 week low of $0.01 and a 52 week high of $0.70.

About BriaCell Therapeutics

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.